Neurology

UZ Leuven has been collaborating on an internationl clinical study on gene replacement in FTD with progranulin mutation.

A new international clinical trial with tofersen confirms that the drug can stop ALS in patients with a SOD1 mutation. With this doctors and researchers show for the first time that, in principle, ALS is a treatable disease. The results have been published in NEJM.

Researchers at UZ Leuven, KU Leuven, VITO and imec have published promising results on the use of a hyperspectral camera to detect protein plaques in the eyes of Alzheimer's patients.